1 - Students will be able to demonstrate a comprehensive understanding of the principles and applications of biotherapeutics
2 - Students will be able to comprehend the challenges of scaling bioprocesses and apply their knowledge to overcome these
3 - Students will be able to analyse, evaluate and communicate biotherapeutics research
4 - Students will be able to work safely and effectively in a biotherapeutics laboratory, both independently and as part of a team
5 - Students will be able to develop effective time management, problem-solving and reporting skills as required in a professional workplace
6 - Students will be able to develop a professional approach to engaging with industry and an applied methodology in preparing for employment opportunities
This course is available through the following application route(s)
The MSc in Biotherapeutics educates students on the practical uses of molecular advances in the discovery of protein and other biomolecular drug candidates and their development into biotherapeutics. It will provide you with a comprehensive understanding of the development of biotherapeutics, beginning with pre-clinical modelling and target identification together with antibody engineering, biochemical and biophysical characterisation, and development issues for bioprocessing.
Systems biology of biotechnological processes and approaches to the analysis of proteomics-based discovery data will be covered in detail together with mathematical modelling, bioinformatics analysis and data integration strategies. Regulatory issues and innovation and commercialisation strategies will also be covered. A practical 6-month drug discovery laboratory project will form a significant component of the experience of how drug candidates are identified and brought through the development pipeline.
- Expert faculty and senior industry practitioners working at the forefront of their disciplines
- Hands-on practical experience in bioprocessing
- Large research component in hi-tech research lab
- Company visits and access to The National Institute for Bioprocessing Research and Training (NIBRT) on campus
About This Course
This graduate degree in Biotherapeutics has been developed in consultation with the Biopharmaceutical industry and is recognised and valued by them. A key feature is the undertaking of a significant drug discovery and development laboratory project which is reviewed by industry partners. This engagement is designed to help graduates identify opportunities in the industry at the earliest stage.
Prospective employers include Novartis, GSK, Eli Lilly and Co., Johnson & Johnson Ltd., Pfizer, Janssen Biologics, AstraZeneca, MSD, Bristol Myers Squibb, Abbott and Sanofi.
Below is a list of all modules offered for this degree in the current academic year. Click on the module to discover what you will learn in the module, how you will learn and assessment feedback profile amongst other information.
Incoming Stage 1 undergraduates can usually select an Elective in the Spring Trimester. Most continuing undergraduate students can select up to two Elective modules (10 Credits) per stage. There is also the possibility to take up to 10 extra Elective credits.
Trimester | Credits | |||
---|---|---|---|---|
Stage 1 Core Modules |
PHAR40230 | Project in Biotherapeutics Dev | 2 Trimester duration (Spr-Sum) | 45 |
Stage 1 Core Modules |
BIOC40180 | Professional Career Development | Autumn | 5 |
Stage 1 Core Modules |
PHAR40200 | Biotherapeutic Pipeline I | Autumn | 5 |
Stage 1 Core Modules |
PHAR40210 | Biotherapeutic Pipeline II | Spring | 5 |
Stage 1 Core Modules |
PHAR40220 | Systems Biology in Drug Dev | Spring | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
BIOC40260 | Biomedical Diagnostics | Autumn | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
BMOL40120 | The Business of Biotechnology and Science | Autumn | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
MICR40010 | Recombinant DNA Technology | Autumn | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
MICR40020 | Microbial and Animal Cell Products | Autumn | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
BMOL40190 | Multicellular Systems | Spring | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
BMOL40360 | Bioprocessing | Spring | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
CELB40160 | HCS Microscopy | Spring | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
MICR40100 | Emerging Issues in Biotechnology | Spring | 5 |
Stage 1 Options - B)5 of: Please choose 5 Option Modules from the 9 Option Modules available to you |
PHAR40240 | Regulatory Affairs for Life Sciences | Spring | 5 |
Associate Professor David O’Connell
Lecturer in Biochemistry and Pharmacology
My core research focus is on the activity of calcium-binding proteins involved in homeostatic mechanisms in the cell using an integrated platform of proteomic technologies. I have patented a novel affinity tag platform for improved protein immobilisation for purification, biophysical analysis and detection in multiple biopharmaceutical applications.
EU fee per year - € 12810
nonEU fee per year - € 29100
***Fees are subject to change
Tuition fee information is available on the UCD Fees website. Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please visit International Scholarships.
The programme is intended for applicants who have an Upper Second Class Honours Degree, or international equivalent, in a biological or chemical science. This includes a BSc in Biotechnology, Biochemistry, Microbiology, Genetics, Neuroscience, Physiology, Pharmacology, Medicinal Chemistry or an equivalent qualification.
Graduates with equivalent qualifications in related areas of science and technology or with proven relevant industrial experience may be considered for places. The number of places is limited and selection will be made on the candidate's performance in his/her primary degree and experience. A significant amount of lab experience will be required, e.g. a laboratory based project or equivalent component(s), at a senior stage of the student's degree.
2 academic references will be required, at least one to be from a science faculty member
Early Applications
In previous years, all spaces on this suite of programmes have been offered by May of the previous academic year. Please submit your application as soon as possible.
English Language Requirements
If English is not your native language, unless you have done your primary degree through English in an English speaking country, an English language qualification is required for all programmes. English Language qualifications include a minimum score of 550 (213 computer based) for Test of English as a Foreign Language (TOEFL), or 6.5 (with a score of 6 obtained in each category) for International English Language Testing System (IELTS). Other evidence of proficiency in English may be accepted such as the Cambridge Certificate. Tests used as evidence of language proficiency must have been completed within the last 12 months.
Students meeting the programme’s academic entry requirements but not the English language requirements, may enter the programme upon successful completion of UCD’s Pre-Sessional or International Pre-Master’s Pathway programmes. Please see the following link for further information http://www.ucd.ie/alc/programmes/pathways/
These are the minimum entry requirements – additional criteria may be requested for some programmes
Full Time option suitable for:
Domestic(EEA) applicants: Yes
International (Non EU) applicants: Yes
How to Apply
General application route(s) for Irish/UK/EU applicants* for International (non-EU) applicants* to Biotherapeutics:
ROWCLASS | Apply to | Application Type | ||
---|---|---|---|---|
showAudience-audienceEU showAudience-audienceInt | F102 Biotherapeutics Master of Science |
Full-Time Commencing September 2024 |
Graduate Taught | Closed |
showAudience-audienceEU showAudience-audienceInt | F102 Biotherapeutics Master of Science |
Full-Time Commencing September 2025 |
Graduate Taught | Apply |